Scientist III, Analytical Development & QC

Oxford BioMedica (UK) Limited

Scientist III, Analytical Development & QC

Salary Not Specified

Oxford BioMedica (UK) Limited, Oxford

  • Full time
  • Permanent
  • Onsite working

Posted 5 days ago, 13 Sep | Get your application in now to be included in the first week's applications.

Closing date: Closing date not specified

job Ref: 1a71de86af5d4117b6c2f70ef89d2ef5

Full Job Description

We are currently recruiting for a Scientist III to join the Analytical Development and QC team. The purpose of this role is to perform and report laboratory-based experiments, in accordance with scientific or regulatory requirements within Containment Level 2 and Containment Level 3 laboratories.

Our ADQC team supports the development of products through analytical testing to facilitate manufacturing and process development, ensuring appropriate quality controls and use of analytics.

Your responsibilities in this role would be:

  • Performing analytical testing as part of QC release

  • Assisting in the development of assays when required

  • Conduct investigations in accordance with correct methodologies and procedures under the direction of Subject Matter Expert/QC Manager/Line Manager


  • Ensuring a high standard of record keeping and documentation of assays and investigations.

  • Presentation of scientific data at internal meetings.

  • Providing training in laboratory procedures.


  • Responsible for the completion of tasks about their criticality.

  • Responsibility for maintenance and compliance of a GxP laboratory area and/or important equipment

  • Work will be conducted in accordance with the OXB Quality Management system.

  • Writing and reviewing of departmental documentation and SOP's.

  • Completion of Quality records (Change control, Deviation, and CAPAs) to a high level in a timely manner

    Educated to a minimum of BSc Degree with basic experience of working in a related environment.

  • An understanding of Virology and gene therapy would be an advantage.

  • Demonstratable competency in performing laboratory tasks and general experimental procedures with expertise in a single area.

  • Laboratory technical experience in cell culture, qPCR and molecular biology.

  • Understanding of laboratory health and safety requirements.

  • Capable of offering reasonable solutions to assay and equipment troubleshooting.

  • Good working knowledge of regulatory requirements, e.g. GMP, GLP, GCP and/or Validation and Quality Management systems.

  • Competent in training operators in complex methods

    Oxford Biomedica is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.


  • Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

    What's in it for you:

  • Highly competitive total reward packages

  • Wellbeing programmes

  • Development opportunities

  • Welcoming, friendly, supportive colleagues

  • A diverse and inclusive working environment

  • Our values are: Deliver Innovation, Be Inspiring and Have Integrity

  • State of the art laboratory and manufacturing facilities


  • We want you to feel inspired every day. We're future-focused and our business is growing rapidly. We succeed together through passion, commitment, and teamwork, and so can you.

    Collaborate. Contribute. Change lives

    We offer:

    Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

    Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient's cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients' cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

    Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise., Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

    Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient's cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients' cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

    Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

    Oxford Biomedica, a FTSE4Good constituent, is headquartered in Oxford, UK. It has locations across Oxfordshire, UK and near Boston, MA, US. Learn more at www.oxb.com, www.oxbsolutions.com, and follow us on LinkedIn, Twitter and YouTube.

    Life at Oxford Biomedica

    We value everyone's unique contribution, we appreciate everyone's individuality, and every job matters.

    Your contributions are recognised and appreciated. Your work-life balance matters. We recognise, develop and use your strengths. It's a place where you are valued as a whole person, as an individual and as part of a team.

    No matter who you are, or what you do, your work will make a significant difference.

    We go the extra mile, every day, because we truly care. We work together as a team to achieve our life changing therapies. Our talented colleagues help to build other people's futures, so can you. We empower each other to be our best.

    We have access to like-minded scientists and engineers, working in the latest technologies.

    Our community of experts create new life-saving cures. Shaping the business' future through collaboration. Our people are on a continuous professional development journey aided by a thought-provoking environment. A place for experts to be stretched, and future experts to be nurtured. We inspire creativity and deliver great science, and so can you.

    Our supportive culture invites talent, while creating future innovators.

    We'll give you a place where you can learn, grow and contribute to the future of cell and gene therapy. We create opportunities and invest in our people, promoting ongoing learning. Our defined career pathways provide opportunities for everyone to achieve their career potential. We make a difference, and so can you.